Evofem Biosciences inks $25m
Evofem Biosciences Inc has secured $25 million in funding from Adjuvant Capital LP.
Evofem Biosciences Inc has secured $25 million in funding from Adjuvant Capital LP.
Copyright PEI Media
Not for publication, email or dissemination